參考文獻/References:
[1] Tsu V, Jerónimo J.Saving the world's women from cervical cancer[J].N Engl J Med,2016,374(26):2509-2511.[2] GoluboviM, Lopiic M,Terzic N,et al.Presence of histopathological premalignant lesions and infection caused by high-risk genotypes of human papillomavirus in patients with suspicious cytological and colposcopy results: A prospective study[J].Vojnosanit Pregl,2017,74(1):24-30.[3] Tadesse W G,Oni A A A, Hickey K P W.Effectiveness of cold coagulation in treating high-grade cervical intraepithelial neoplasia: the human papillomavirus evidence of cure[J].J Obstet Gynaecol,2019,39(7):965-968.[4] 方佳, 陳鳳燕.宮頸癌前病變應(yīng)用P16/Ki-67免疫細(xì)胞化學(xué)雙染檢查的診斷價值[J].中國當(dāng)代醫(yī)藥, 2018, 25(12):125-127.[5] Finegan M M, Han A C, Edelson M I, et al.p16 expression in squamous lesions of the female genital tract[J].Journal of Molecular Histology, 2004, 35(2):111-113.[6] 王立宏, 王雯.P16、Ki-67在宮頸上皮內(nèi)瘤樣變中的表達及其意義[J].醫(yī)學(xué)臨床研究, 2016,33(10):1908-1910.[7] Scholzen T, Gerdes J.The Ki-67 protein: from the known and the unknown[J].J Cell Physiol,2000,182(3):311-322.[8] 史勉.P16、Ki-67免疫組化染色在宮頸上皮內(nèi)瘤變分級中的診斷價值[J].當(dāng)代醫(yī)學(xué),2021,27(2):63-65.[9] Azizan N, Hayati F,Tizen N M S,et al.Role of co-expression of estrogen receptor beta and Ki-67 in prostate adenocarcinoma[J].Investig Clin Urol,2018,59(4):232-237.[10] 肖燕,夏琛,金冬梅,等.高危型人乳頭瘤病毒、P16和ki-67在宮頸上皮內(nèi)瘤變臨床意義及相互關(guān)系[J].現(xiàn)代生物醫(yī)學(xué)進展,2021,21(1):70-78.[11] 崔凱,張利平.p16蛋白、Ki-67抗原檢測在宮頸上皮內(nèi)瘤變中的診斷價值[J].檢驗醫(yī)學(xué)與臨床,2019,16(24):3704-3706.